Dixon J L, Copeland L A, Zeber J E, MacCarthy A A, Reznik S I, Smythe W R, Rascoe P A
Surgery Service, Central Texas Veterans Health Care System, Temple, TX, USA.
Department of Surgery, Scott & White Healthcare, Temple, TX, USA.
Dis Esophagus. 2016 Oct;29(7):747-751. doi: 10.1111/dote.12402. Epub 2015 Oct 12.
In the past 30 years, the incidence of esophageal adenocarcinoma (EAC) has increased more rapidly than any other cancer in the United States. The prevalence of obesity and diabetes mellitus has drastically increased as well. We explored the potential association between obesity, diabetes mellitus, and EAC. By means of retrospective interrogation of an administrative database from fiscal year 2005-2009, we identified two cohorts. The cancer cohort was defined as patients with adenocarcinoma of the distal esophagus or gastric cardia. The comparison cohort contained patients with gastroesophageal reflux disorder (GERD; diagnosis coupled with a procedure code for fundoplication). Patient data, including demographic measures, diagnoses of obesity, diabetes mellitus, dyslipidemia, alcohol abuse, and nicotine dependence were examined. A logistic regression model identified risk factors for development of EAC. The sample included 2,836 patients identified as having either EAC (1,704) or fundoplication with GERD (1,132). Although slightly higher percentages of the benign cohort were obese, the cancer cohort had more diabetics (30.8% vs. 14.8%; chi-square = 94.5; P < 0.0001). In a logistic regression analysis adjusting for comorbidity and lifestyle factors, diagnosis of diabetes mellitus was significantly associated with esophageal cancer as opposed to GERD without cancer (OR = 2.2; 95% confidence interval [CI] 1.7-2.8). Nicotine dependence was also identified as a risk factor (OR = 1.7; 95% CI 1.4-2.0). We identified a potential association between diabetes mellitus and adenocarcinoma of the esophagus or gastric cardia. This association appears to be independent of obesity. Additionally, nicotine dependence was identified as a risk factor for EAC.
在过去30年中,食管腺癌(EAC)的发病率在美国比其他任何癌症增长得都更快。肥胖症和糖尿病的患病率也急剧上升。我们探讨了肥胖症、糖尿病与食管腺癌之间的潜在关联。通过对2005 - 2009财年行政数据库的回顾性查询,我们确定了两个队列。癌症队列定义为远端食管或贲门腺癌患者。比较队列包含胃食管反流病(GERD;诊断加上胃底折叠术的手术编码)患者。检查了患者数据,包括人口统计学指标、肥胖症、糖尿病、血脂异常、酒精滥用和尼古丁依赖的诊断情况。一个逻辑回归模型确定了食管腺癌发生的危险因素。样本包括2836名被确定患有食管腺癌(1704例)或因胃食管反流病接受胃底折叠术(1132例)的患者。虽然良性队列中肥胖者的比例略高,但癌症队列中的糖尿病患者更多(30.8%对14.8%;卡方检验=94.5;P<0.0001)。在一项针对合并症和生活方式因素进行调整的逻辑回归分析中,糖尿病诊断与食管癌显著相关,而非与无癌症的胃食管反流病相关(比值比[OR]=2.2;95%置信区间[CI]1.7 - 2.8)。尼古丁依赖也被确定为一个危险因素(OR = 1.7;95% CI 1.4 - 2.0)。我们确定了糖尿病与食管或贲门腺癌之间的潜在关联。这种关联似乎独立于肥胖症。此外,尼古丁依赖被确定为食管腺癌的一个危险因素。